Pfizer Inc
(NYSE: PFE)
▼
32.60
-0.20
-0.61%
1 Day
Open
32.34
Volume (Avg)
40.54M (24.68M)
52Wk Range
27.51-33.50
Top Stories
-
Pfizer Hit by Stronger Dollar, Patent Losses
Wall Street Journal 4 hrs ago -
Pfizer Hit by Stronger Dollar, Patent Losses, Lawsuit Settlement -- 3rd Update
NASDAQ 4 hrs ago -
Pfizer's 2015 forecast disappoints, crimped by generics, dollar
Reuters 7 hrs ago -
Pfizer to pay $400 million to avert investor class action trial
Reuters 8 hrs ago -
PFIZER INC (PFE) Earnings Report: Q4 2014 Conference Call Transcript
The Street 8 hrs ago -
Pfizer’s Deal Desires Move From Drug Pipeline to Products
Businessweek 10 hrs ago
-
Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog
Investopedia 11 hrs ago -
Pfizer Forecast Falls Short on Patent Expiration, Currency
Businessweek 13 hrs ago -
Pfizer Inc.'s Fourth-Quarter Earnings Hint at Big Things to Come
The Motley Fool 13 hrs ago -
Pfizer (PFE) Is Today's Pre-Market Laggard Stock
The Street 14 hrs ago -
Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead
The Motley Fool 15 hrs ago -
Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog
NASDAQ 22 hrs ago
-
Pfizer to Cut Prevenar 13 Price Again
Wall Street Journal 1 day ago -
One Put, One Call Option To Know About for Pfizer
Forbes 1 day ago -
Pfizer Warns U.K. Doctors About Prescribing Generic Lyrica For Pain
Benzinga 1/13/2015 -
Pfizer Warns U.K. Doctors About Prescribing Generic Lyrica For Pain
Benzinga 1/13/2015 -
Pfizer developing PCSK9 pill, vaccine to lower cholesterol
Reuters 1/13/2015 -
23andMe Gives Pfizer Access To Its Genome Database
Fast Company 1/13/2015
-
Pfizer Partners With DNA Research Firm To Study Lupus Disease
The Business Insider 1/13/2015 -
One Put, One Call Option To Know About for Pfizer
Forbes 1/12/2015 -
Pfizer partners with DNA research firm to study lupus disease
Reuters 1/12/2015 -
Pfizer partners with DNA research firm to study lupus disease
CNBC 1/12/2015 -
Pfizer, FDA in talks on prescription details for key breast cancer drug
FOX News 1/8/2015 -
Pfizer, FDA in talks on prescription details for key breast cancer drug
Reuters 1/8/2015
-
Drug Buying Spree Still Bustling; Pfizer Leads Hunt
Bloomberg 1/7/2015 -
Health-Care Stocks Avoid Market Malaise
Wall Street Journal 1/7/2015 -
Update: Pfizer Improves Prospects With Acquisition Of Redbiotec
Seeking Alpha 1/6/2015 -
Pfizer continues vaccine push, buys Switzerland's Redvax
The Huffington Post 1/6/2015 -
Pfizer Acquires Redvax GmbH
Stockhouse 1/5/2015 -
Cempra’s lead oral antibiotic meets main goal in late-stage trial
FOX News 1/5/2015
-
Pfizer Acquires Redvax for its Potential Herpes Vaccine
news.morningstar.com 1/5/2015 -
Stock Quote Pfizer Inc
Morning Star 1/5/2015 -
Novartis, Pfizer and Bristol-Myers hit the gas on R&D last year
Fierce Biotech 5 hrs ago -
Pfizer Strikes $400M Deal To End Shareholder Suit
Law 360 5 hrs ago -
US company outlooks worry investors, sending stocks lower
The Roanoke Times 5 hrs ago -
Still looking to buy, Pfizer revenue, profit hit by currency-exchange rates
Philadelphia Daily News 5 hrs ago
-
Pfizer considers splitting company or going after M&A
in-Pharma 8 hrs ago -
Drugmaker Pfizer's 4Q profit plunges on lower sales, higher research, legal and other costs
US News and World Report 9 hrs ago -
Bristol-Myers, Caterpillar, Pfizer, P&G Net Decline
ticker.com 10 hrs ago -
Pfizer’s drug earnings reach $1.2B in quarter
Salt Lake Tribune 10 hrs ago -
3M, Du Pont Net Climb; Bristol-Myers, Pfizer, P&G Net Tumble
123Jump 10 hrs ago -
Pfizer ekes out gains on a down market day
Market Watch 11 hrs ago
-
Pfizer Q4 Adj. Profit Beats View, But Outlook Disappoints
Realtime Business News 12 hrs ago -
Pfizer Inc. (PFE) Updates FY15 Earnings Guidance
Intercooler 12 hrs ago -
Healthcare Stocks: Merck & Co. Inc. (NYSE:MRK), GlaxoSmithKline plc (NYSE:GSK), Mylan, Inc. (NASDAQ:MYL), Pfizer Inc. (NYSE:PFE)
emarketsdaily.com 12 hrs ago -
Pfizer Inc. (PFE) Is Challenging The Highs After Q4 Report
Realtime Business News 13 hrs ago -
Pfizer share price down, projects lower sales on stronger dollar
binarytribune.com 13 hrs ago -
Pfizer Beats on Q4 Earnings, Guides Below Expectations
ZACKS 13 hrs ago
-
Pfizer forecast falls short on patent expiration, strong dollar
Worcester Telegram & Gazette 14 hrs ago -
Pfizer (PFE) Trading Near $33.29 Resistance Level
Market Intelligence Center 14 hrs ago -
Pfizer Inc. Beats Q4 Estimates (PFE)
Dividend 14 hrs ago -
Pfizer tops 4Q earnings and revenue expectations
Fox Business 14 hrs ago -
Pfizer Inc. (PFE) Q4 Earnings Preview: High Organic Growth In Vaccines And Oncology To Offset Loss Of Patents
bidnessetc.com 14 hrs ago -
Pfizer Inc. (PFE) Will Further Reduce Prevenar 13 Price In The World’s Poorest Countries
bidnessetc.com 15 hrs ago
-
Pfizer Inc., Procter & Gamble Co Edge Out Earnings Estimates
Value Walk 15 hrs ago -
Pfizer (PFE) Issues Quarterly Earnings Results
Ticker Report 15 hrs ago -
Pfizer (PFE) Releases Quarterly Earnings Results
Intercooler 15 hrs ago -
Pfizer's profit, sales outlook misses expectations
Market Watch 15 hrs ago -
Apple, Pfizer, Yahoo earnings in focus
Inside Fidelity 16 hrs ago -
Market Update (NYSE:PFE): Pfizer Commits to Further Reduce Price for Prevenar 13 in the World’s Poorest Countries Through 2025
Jutia Group 1 day ago
